Want to join the conversation?
For 4Q15, $PVH expects non-GAAP EPS to be $1.37-1.47, including about $0.33 per share negative impact primarily related to foreign currency exchange rates. Excluding this negative impact, non-GAAP EPS is expected to be in the range of a 3% decrease to a 2% increase. In 4Q15, revenue is expected to remain flat.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?